. Sixweek-old chickens were injected with subgroup A Rous sarcoma virus (RSV). The tumors were scored for size at 2, 3, 4, 6, 8, and 10 weeks postinoculation. A tumor profile index (TPI) was assigned to each bird based on the six tumor scores. Two experiments with two trials each were conducted. In Experiment 1, chickens (n = 84) were inoculated with 30 pock-forming units (pfu) RSV. There was no significant B genotype effect on tumor growth over
INTRODUCTION
Chicken major histocompatibility (B) complex molecules are encoded by two class B IIβ genes and two class B Iα genes, one of which is primarily expressed for each class (Kaufman et al., 1999) . This simple organization means that particular B complex genotypes influence the response to viral, bacterial, and parasitic diseases (Dietert et al., 1991; Kaufman et al., 1995; 1999) . Collins et al. (1977) and Schierman et al. (1977) first reported the central role of the B complex in determining the outcome of Rous sarcoma virus (RSV) tumors. Collins et al. (1977) found that Rous sarcoma growth is regressive in B and B
13
B 13 genotypes exhibit 92% and 4% tumor regression, respectively (Schierman et al., 1977) .
The B complex also controls the tumor growth induced by subviral constructs carrying the v-src oncogene but 1 This is Scientific Contribution Number 2039 from the New Hampshire Agricultural Experiment Station. lacking viral replication genes. Taylor et al. (1992 Taylor et al. ( , 1994 observed that congenic Line 6.6-2 (B 
B
4 chickens regressed v-src tumors, whereas B 4r1 B 4r1 progressed tumors (Svoboda et al., 1992 (Plachy et al., 1994) . The B Q haplotypes, homozygous in inbred Jungle Fowl Line UCD 001, used in the present study are of interest because of the serological and electrophoretic similarity to the significantly Marek's disease (MD) resistant B 21 haplotype (Abplanalp et al., 1985; Miller et al., 1984 tested for response against three different strains of MD virus (Abplanalp et al., 1985) , had higher weight gain than B 17 B 17 chickens after challenge with 10,000 Eimeria tenella oocysts (Caron et al., 1997) (Cheng and Crittenden, 1994 ) for genome mapping. The purpose of the present study was to examine growth of RSV-induced tumors in chickens having segregating haplotype combinations of B Q and B
17
. Because of the unknown nature of the response of the B Q
B
Q haplotype, the test was conducted with a high and a low dose of RSV.
MATERIALS AND METHODS

Stock
Chickens for these experiments were produced from the cross of Line UCD 001 (B 
17
. Eggs were incubated at the University of New Hampshire Poultry Research Farm. Each chick was wing-banded for identification.
Chicks were housed initially in heated brooder batteries for 6 wk. After 6 wk of age, chicks were transferred to isolation cages for the remainder of the experiment. Food and water were available ad libitum. Newcastle-bronchitis and MD vaccinations were administered at hatch and 10 d, respectively. At 3 wk of age, B system antigens were typed in agglutination assays with specific antisera raised for the B haplotypes transmitted by the parental stocks . Blood (0.5 mL) was drawn from the wing vein into anticoagulant solution (68 µM sodium citrate/72 µM sodium chloride) and was shipped overnight with ice packs to Northern Illinois University. One hundred micoliters of antisera specific for the B haplotype of interest was mixed with 50 µL of a 2% suspension of washed red blood cells in 10 × 75 mm tubes. After incubation at room temperature for 2 h, the mixture was incubated overnight at 3 C. Cells were resuspended and read for agglutination after 1 h at room temperature.
RSV Challenge and Tumor Scoring
Six-week-old chickens were wingweb inoculated with subgroup A RSV. Two experiments were conducted with each having two trials. In Experiment 1, 84 chickens received 30 pock-forming units (pfu) RSV, whereas 141 chickens received 15 pfu RSV in Experiment 2. Tumor size was scored six times over a 10-wk period with values from 0 = no tumor to 7 = death from tumor growth during the experiment (Collins et al., 1985) . A tumor profile index (TPI) that indicated the degree of tumor growth was assigned based on the six tumor size scores. The TPI was according to Collins et al. (1985) , where 1 = complete regression by 70 d, or a decreasing slope, or complete regression by 56 d followed by recurrence; 2 = general upward trend, or plateau; slight regression after 56 
Statistical Analysis
Tumor growth data from each experiment were evaluated by repeated measures ANOVA with hatch and B genotype as main effects. The TPI values were analyzed by ANOVA. Differences between B genotypes were determined using the Student-Neumann-Kuels test (P ≤ 0.05). Mortality differences were determined by chi-square analysis. Figure 1B) . None of the TPI were significantly different, indicating equal plateaus of tumor growth for the three genotypes. No differences in mortality were observed.
RESULTS
Tumors
In Experiment 2, the birds were inoculated with a lower dose (15 pfu) of RSV. The 56.0% (79/141) of the birds that developed tumors was much less than in Experiment 1. Significant effects of time (P ≤ 0.001) and the time × B genotype interaction (P ≤ 0.001) were found in the analysis of tumor growth (Figure 2A 
DISCUSSION
This study examined the effect of B 17 and B Q MHC haplotypes on RSV tumor outcome. In the first experiment, approximately 83% of chickens inoculated with 30 pfu RSV developed tumors, and the TPI of these chickens indicated a plateau of tumor growth. There were no significant differences in tumor growth patterns over time among the three B genotypes, indicating that B Q and B
17
haplotype combinations do not exert a differential effect after inoculation with 30 pfu RSV. This dose appears to have overwhelmed any response differences attributable to the B complex. Vincent and Taylor (1988) (Plachy, 1985) .
Similar complementary effects in the antitumor response have been observed in noninbred Line UNH 105 New Hampshire chickens (Collins et al., 1979 (Collins et al., , 1985 Brown et al., 1982; Taylor et al., 1988; Lukacs et al., 1989) . Collins et al. (1979) Brown et al. (1982) described the antitumor response as a complex reaction to various viral and tumor antigens. Lukacs et al. (1989) suggested that the MHC molecules found in particular heterozygotes may facilitate recognition of foreign antigens. A heterozygote may recognize additional antigens than the homozygote, or the heterozygote may have greater recognition of the same antigens. Kaufman et al. (1995) found that the B 12 regressor haplotype class I molecule recognized more possible octamer and nonamer peptides from the Prague strain C RSV than did the B 4 progressor haplotype class I molecule. Heterozygous genotypes, such as B Q B 17 in the current study, would recognize antigenic peptides of the component haplotypes. Complementation would occur because a heterozygote recognizes more antigens than the homozygote, or the heterozygote may have greater recognition of the same antigens. These two possibilities are indistinguishable at present. Heinzelmann et al. (1981a,b) demonstrated interaction between MHC and tumor-associated molecules. In that study, B 2 B 2 chickens, which normally regress Rous sarcoma, had greater tumor progression if they were previously made tolerant to the B 5 antigen from progressor chickens. The interaction of viral or RSV-induced tumor cell antigens depends largely on T cells to produce tumor regression (Cotter et al., 1976; Gilmour et al., 1983; Powell et al., 1987) . In addition, Powell et al. (1987) found that regressing tumors, but not progressing tumors, contain focal lymphoid infiltrations, consisting of mostly T cells. Powell and colleagues (1987) also observed that B-L class II MHC molecules are present in regressing tumors and absent in progressing tumors. The appearance of these B-L molecules suggests that their proteins may be important in antigen presentation to helper T cells or be a structure for class II specific cytotoxic T cells (Powell et al., 1987 . The powerful B complex genotype influence does not preclude the effect of non-MHC genes in the current study.
Two factors affect RSV tumor growth: 1) growth and subsequent division of tumor cells, and 2) recruitment of new cells via viral-replication genes . The MHC effect on tumor outcome influences either of these factors. In the present study, the higher dose (30 pfu) RSV overcame any immune response differences among B 
